Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.
about
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in CambodiaMultiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variantsArtemisinin Resistance in Plasmodium falciparum MalariaGenetic diversity of Plasmodium falciparum isolates from concurrent malaria and arbovirus co-infections in Kedougou, southeastern SenegalPolymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from GabonEfficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, SudanIn vivo transcriptional profiling of Plasmodium falciparumGenetic diversity of Plasmodium falciparum isolates from uncomplicated malaria cases in Ghana over a decadeThe Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria VaccineSurface co-expression of two different PfEMP1 antigens on single plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1Structural polymorphism in the promoter ofpfmrp2confersPlasmodium falciparumtolerance to quinoline drugsDeclining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern IndiaRDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros IslandsClinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introductionSustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes"Sexual" population structure and genetics of the malaria agent P. falciparumPrimaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunateA randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in PeruSafety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina FasoHigh resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trialIn vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genesReduced susceptibility of Plasmodium falciparum to artesunate in southern MyanmarThe suitability of P. falciparum merozoite surface proteins 1 and 2 as genetic markers for in vivo drug trials in YemenEfficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trialMalaria transmission in non-endemic areas: case report, review of the literature and implications for public health managementHigh-speed shaking of frozen blood clots for extraction of human and malaria parasite DNA.Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins.Population genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites.RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping.No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.High resolution melting: a useful field-deployable method to measure dhfr and dhps drug resistance in both highly and lowly endemic Plasmodium populations.Population genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens.Bottleneck effects on vaccine-candidate antigen diversity of malaria parasites in Thailand.Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae.Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trialAntibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolatesImmunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes.
P2860
Q21034146-60256E55-6D45-4C25-A121-F7FBE6877CC8Q21034153-BBCA609E-1C80-456F-AA40-882D6C78B2D3Q22061852-F3B6153A-1638-4CF8-89FA-3E809E4401A6Q24288875-02E4BFCC-E3DA-46AC-B009-297F2D38BB65Q24800390-69267972-C560-44E8-8461-CC41E8E3D714Q24801453-45309C73-B55E-4494-B595-5D8341E9021FQ24802139-4A12AD8D-7BA2-4B8F-B4FC-7C3F9BF32945Q26700160-C83E5401-EFD8-4895-ADCE-6375D1240F63Q27300745-DCA1FABA-6BA2-46BD-8856-FEF1CE80DE3AQ27313623-37CC96B5-A806-413C-A614-5DA686D07573Q27861940-A50675E4-F2A8-48C1-90D1-51856132C4BCQ28125909-8A22954D-651B-4765-898A-C11FCEC85ACFQ28125925-9F1E6CD3-25FF-407F-BA41-8CE1381B21ECQ28125932-95A4969C-F8BB-436C-A025-1C9E428FA369Q28125936-585B2A50-1EE5-4A8F-B7A1-3EB9F5F8CD5DQ28469245-3974653E-E893-456A-B959-2E25FEC692F0Q28469316-87282EC4-0193-4ED8-9D48-4886DA2C5247Q28469333-1238CABA-9833-42BD-AB7C-9B6315AFED2EQ28472182-BCF8C0B5-EB3B-42F7-ACD8-625A436C4B77Q28474860-5B1735E8-E081-4B0D-8034-BCD6C18187A2Q28478138-57A04A0C-0943-45E5-B4C8-18F415365177Q28484068-684B3329-811D-4CC0-99E6-9BAAD3F29E5EQ28487881-0EB3F405-AF26-44BC-89E2-C242F9860CECQ28534510-1EEC337B-5BF1-4016-B403-B23BB693F9F9Q28541521-9D05331E-9A5C-4BBE-85F0-0A811F8CF8A2Q30228073-909AE759-0497-4016-9352-89DA2653F3B3Q30504134-D74D74B7-90BA-4C38-B792-DA187E9FFD3CQ30895708-6271435F-D03A-4023-A5CA-7E35EBE46365Q30984141-C90FA469-722E-4299-AB29-39B26942E7DAQ31076942-D22BB237-26DF-4789-A70F-579FD2AB62E4Q33251913-B5D17CF9-49CB-4DED-877C-211B4C7F841FQ33301011-E0BBE02B-3FFA-4A91-ADB5-38A72B1E0D0DQ33498521-0033B81E-E412-4C70-A8B7-60B9994187B8Q33576274-B7F30025-DD93-4157-B539-8A748C9A744EQ33691419-8FBC7DA4-EE2E-413A-ABF7-CBF7C20F9028Q33759387-38548EE1-6093-4DBA-83DF-B35BA9E0FDB3Q33769097-048A8E37-9DCA-4B8D-AD56-83F35E6D9EC4Q33784329-BA99F8F0-80EE-4817-AB74-B96F7D928768Q33822296-D07113BA-92DC-46D0-B422-0D6FC5B775D8Q33826076-BB1BB1B0-5DBD-43D8-83F4-9EAA2B5F075B
P2860
Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Biased distribution of msp1 an ...... parum populations in Thailand.
@en
Biased distribution of msp1 an ...... parum populations in Thailand.
@nl
type
label
Biased distribution of msp1 an ...... parum populations in Thailand.
@en
Biased distribution of msp1 an ...... parum populations in Thailand.
@nl
prefLabel
Biased distribution of msp1 an ...... parum populations in Thailand.
@en
Biased distribution of msp1 an ...... parum populations in Thailand.
@nl
P2093
P2860
P921
P1476
Biased distribution of msp1 an ...... parum populations in Thailand.
@en
P2093
P2860
P304
P356
10.1016/S0035-9203(99)90120-7
P577
1999-07-01T00:00:00Z